Cadila Healthcare informs about press release

22 Nov 2018 Evaluate

Cadila Healthcare has informed about press release dated November 22, 2018 titled ‘Zydus receives approvals from the USFDA for Atorvastatin Calcium Tablets and Dimethyl Fumarate Delayed-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

889.80 -3.65 (-0.41%)
28-Jan-2026 10:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1616.00
Dr. Reddys Lab 1224.65
Cipla 1318.70
Zydus Lifesciences 889.80
Lupin 2123.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×